Catherine Ramsey
Stock Analyst at Baird
(1.16)
# 2,967
Out of 4,667 analysts
39
Total ratings
40%
Success rate
1.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Maintains: Outperform | $46 → $48 | $41.11 | +16.76% | 5 | Nov 19, 2024 | |
| NTRA Natera | Maintains: Outperform | $120 → $160 | $167.88 | -4.69% | 5 | Nov 13, 2024 | |
| ILMN Illumina | Maintains: Neutral | $124 → $139 | $131.68 | +5.56% | 4 | Nov 6, 2024 | |
| RVTY Revvity | Maintains: Outperform | $136 → $138 | $111.33 | +23.96% | 3 | Nov 5, 2024 | |
| CSTL Castle Biosciences | Maintains: Outperform | $37 → $39 | $28.45 | +37.08% | 7 | Nov 5, 2024 | |
| WAT Waters | Maintains: Neutral | $319 → $312 | $357.70 | -12.78% | 7 | May 8, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $695 → $665 | $512.92 | +29.65% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $128.58 | +24.44% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $52.70 | +42.31% | 1 | Aug 3, 2022 |
Twist Bioscience
Nov 19, 2024
Maintains: Outperform
Price Target: $46 → $48
Current: $41.11
Upside: +16.76%
Natera
Nov 13, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $167.88
Upside: -4.69%
Illumina
Nov 6, 2024
Maintains: Neutral
Price Target: $124 → $139
Current: $131.68
Upside: +5.56%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $136 → $138
Current: $111.33
Upside: +23.96%
Castle Biosciences
Nov 5, 2024
Maintains: Outperform
Price Target: $37 → $39
Current: $28.45
Upside: +37.08%
Waters
May 8, 2024
Maintains: Neutral
Price Target: $319 → $312
Current: $357.70
Upside: -12.78%
Thermo Fisher
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $512.92
Upside: +29.65%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $128.58
Upside: +24.44%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $52.70
Upside: +42.31%